| Cas No.: | 156722-18-8 |
| 名称: | (3S,5R,8R,9S,10S,13S,14S,17S)-17-(furan-3-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol |
| 别名: | PST 2238, PST-2238, AC1L4BGU, SureCN1716210, UNII-P848LCX62B, 17-(3-Furyl)-5beta-androstane-3,14,17-triol, CHEMBL2068971, 156722-18-8 |
| SMILES: | C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(C5=COC=C5)O)O)C)O |
| 分子式: | C23H34O4 |
| 分子量: | 374.51366 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Rostafuroxin: an ouabain-inhibitor counteracting specific Forms of hypertension.For the detailed information of Rostafuroxin, the solubility of Rostafuroxin in water, the solubility of Rostafuroxin in DMSO, the solubility of Rostafuroxin in PBS buffer, t |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
